Prostate cancer
High-risk non-metastatic prostate cancer: the devil is in the details
Obiettivo della formazione: To provide insight into factors determining treatment appropriateness in high-risk non-metastatic PCa. To clarify if there a role for systemic therapy in clinical practice for this patient population.
Specializzazione: Urology, medical oncology, radiation oncology
Pubblico target: CME: intermediate-advanced | Residents: senior
Aggiornamento più recente: July 2021
Premessa:
Most patients with high-risk prostate cancer (PCa) will need a multimodal treatment approach. However, not all high-risk patients are at the same risk of disease progression or death.